CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to understand the evolution of multidrug resistance in infectious diseases and cancer. By conducting large-scale experiments with bacterial pathogens, it seeks to characterize genetic mutations that contribute to resistance and develop methodologies to study these evolutionary dynamics.
Drug resistance is limiting our ability to treat most infectious diseases and forms of cancer.
Indeed this relentless evolution is the major driver of treatment failure for diseases that are responsible for over half of the global disease related mortality.
Yet, the underlying principles that guide this evolutionary response are poorly understood, in particular with regards to understanding the impact of multidrug treatment.
LimitMDR will characterize evolutionary trajectories leading to multid…
TECHNICAL UNIVERSITY OF DENMARK DTU
DANMARKS TEKNISKE UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
